...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >The effects of the 5-hydroxytryptamine(1A) agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity.
【24h】

The effects of the 5-hydroxytryptamine(1A) agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity.

机译:5-羟基色胺(1A)激动剂8-羟基-2-(二正丙基氨基)四氢化萘对自发活性,可卡因诱导的过度活跃和行为敏化的影响:运动活动的微观分析。

获取原文
获取原文并翻译 | 示例

摘要

The influence of the 5-hydroxytryptamine(1A) agonist 8-hydroxy-2-(di-n-propylamino)tetralin (DPAT) on locomotor hyperactivity induced by the acute and chronic administration of cocaine was assessed. Horizontal activity was measured in the periphery and center of an open field test enclosure equipped with photobeams; vertical activity was also recorded. Peripheral hyperactivity induced by an acute administration of cocaine (10 or 20 mg/kg) was significantly enhanced by 0.2 mg/kg DPAT. In contrast, central and vertical activities were reduced in a dose-related manner by DPAT (0.1 and 0.2 mg/kg); DPAT also suppressed central (0.2 mg/kg) and vertical (0.1 and 0.2 mg/kg) activities when administered alone. Similar observations were made on day 1 of chronic treatment with DPAT (0, 0.1, or 0.2 mg/kg) injected 15 min before an injection of cocaine (0, 10, or 15 mg/kg) administered twice daily for 7 days. By day 7 of repeated DPAT treatment, sensitization of DPAT-evoked peripheral activity developed, which contrasted with tolerance to the central and vertical hypoactivity evoked by DPAT. Sensitization developed to the repeated treatment with 15 mg/kg cocaine but not 10 mg/kg cocaine. Interestingly, enhancements of all activity measures were observed between days 1 and 7 in rats cotreated with DPAT plus either dose of cocaine. This sensitization to DPAT plus cocaine was expressed on challenge with DPAT and cocaine but not with cocaine alone. The present study implies that the stimulation of 5-hydroxytryptamine(1A) receptors is capable of modulating the hyperactivity evoked by cocaine, possibly via modulation of the mesoaccumbens dopamine circuit thought to mediate the behavioral effects of cocaine.
机译:评估了5-羟基色胺(1A)激动剂8-羟基-2-(二正丙基氨基)四氢萘(DPAT)对可卡因急性和慢性给药所引起的运动亢进的影响。在配备有光束的开放式试验箱的外围和中心测量水平活动;垂直活动也被记录下来。急性给予可卡因(10或20 mg / kg)引起的周围机能亢进被0.2 mg / kg DPAT显着增强。相反,DPAT(0.1和0.2 mg / kg)以剂量相关的方式减少了中枢和垂直活动。单独给药时,DPAT还抑制中枢(0.2 mg / kg)和垂直(0.1和0.2 mg / kg)活动。在慢性治疗的第1天,用15分钟注射的DPAT(0、0.1或0.2 mg / kg)进行了类似的观察,然后每天两次注射可卡因(0、10或15 mg / kg),连续7天。到重复进行DPAT治疗的第7天,DPAT引起的周围活动敏化程度提高,这与DPAT引起的中枢和垂直机能减退的耐受性形成对比。过敏反应发展为用15 mg / kg可卡因重复治疗,但没有用10 mg / kg可卡因重复治疗。有趣的是,在用DPAT加任一剂量的可卡因共同治疗的大鼠中,在第1天至第7天之间观察到所有活性指标的增强。对DPAT加可卡因的敏化是在用DPAT和可卡因攻击时表达出来的,而不是仅用可卡因攻击。本研究表明,对5-羟基色胺(1A)受体的刺激能够调节可卡因引起的机能亢进,可能是通过调节介导可卡因行为的中能累积多巴胺回路来实现的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号